natgillin/translations-raw huggingface dataset:
Talk to your doctor before taking Rivastigmine Sandoz 
Obratite se svom liječniku prije nego uzmete Rivastigmin Sandoz
A mild eye/mucosal irritation potential of rivastigmine was identified in a rabbit study. 
Primijećen je potencijal rivastigmina za blagu iritaciju oka/sluznice u ispitivanju na kunićima.
Rivastigmine Sandoz 1.5 mg hard capsules Rivastigmine Sandoz 3 mg hard capsules Rivastigmine Sandoz 4.5 mg hard capsules Rivastigmine Sandoz 6 mg hard capsules 
Rivastigmin Sandoz 1,5 mg tvrde kapsule Rivastigmin Sandoz 3 mg tvrde kapsule Rivastigmin Sandoz 4,5 mg tvrde kapsule Rivastigmin Sandoz 6 mg tvrde kapsule rivastigmin
Restlessness Hallucination, visual Depression Aggression 
Halucinacije, vizualne Depresija
One of the inactive ingredients in Rivastigmine Sandoz oral solution is sodium benzoate. 
Jedan od neaktivnih sastojaka oralne otopine Rivastigmin Sandoz je natrijev benzoat.
CARTON FOR HDPE BOTTLE LABEL FOR HDPE BOTTLE 
KUTIJA ZA HDPE BOČICU NALJEPNICA ZA HDPE BOČICU
By blocking these enzymes, Rivastigmine Sandoz allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer's disease and dementia associated with Parkinson's disease. 
Blokirajući te enzime, Rivastigmin Sandoz omogućava povećanje razina acetilkolina u mozgu, što pomaže u smanjivanju simptoma
If you take more Rivastigmine Sandoz than you should 
Ako uzmete više kapsula Rivastigmin Sandoz nego što ste trebali
Patients with severe hepatic impairment have not been studied, however, rivastigmine capsules may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 5.2). 
Nisu proučavani bolesnici s teškim oštećenjem jetre, no kapsule rivastigmina mogu se koristiti u ovoj populaciji bolesnika uz pažljivo praćenje (vidjeti dijelove 4.4 i 5.2).
Total patients studied Total patients with pre-defined AE(s) Tremor 
Ukupan broj bolesnika s unaprijed definiranom nuspojavom (nuspojavama) Tremor
• Take Rivastigmine Sandoz twice a day in the morning and evening with food. 
• Trebate uzimati Rivastigmin Sandoz dva puta na dan, ujutro i uvečer uz obrok.
However, a greater treatment effect was seen in Parkinson's disease patients with moderate dementia. 
No veći terapijski učinak uočen je u bolesnika s Parkinsonovom bolešću s umjerenom demencijom.
Pre-defined adverse events that may reflect worsening of parkinsonian symptoms in patients with dementia associated with Parkinson's disease 
Unaprijed definirane nuspojave koje mogu odražavati pogoršanje simptoma parkinsonizma u bolesnika s demencijom povezanom s Parkinsonovom bolešću
CARTON FOR GLASS BOTTLE LABEL FOR GLASS BOTTLE 
NALJEPNICA ZA STAKLENU BOČICU
Rare Very rare 
Rijetko Vrlo rijetko
- Magnesium stearate - Hypromellose - Silica, colloidal anhydrous 
- magnezijev stearat - hipromeloza - silicijev dioksid, koloidni, bezvodni
Oral studies in pregnant rats and rabbits gave no indication of teratogenic potential on the part of rivastigmine. 
U ispitivanjima oralne primjene lijeka na skotnim ženkama štakora i kunića nije bilo naznaka teratogenog potencijala rivastigmina.
Table 2 shows the adverse reactions reported during clinical studies conducted in patients with dementia associated with Parkinson's disease treated with rivastigmine capsules. 
Tablica 2 pokazuje nuspojave zabilježene tijekom kliničkih ispitivanja provedenih u bolesnika s demencijom povezanom s Parkinsonovom bolešću liječenih rivastigminskim kapsulama.
There is no relevant use of Rivastigmine Sandoz in the paediatric population in the treatment of Alzheimer's disease. 
Ne postoji značajna primjena Rivastigmina Sandoz u pedijatrijskoj populaciji kod liječenja
Bradycardia Arial fibrillation Atrioventricular block Sick sinus syndrome 
Bradikardija Fibrilacija atrija Atrioventrikularni blok
The efficacy of rivastigmine has been established through the use of three independent, domain specific, assessment tools which were assessed at periodic intervals during 6 month treatment periods. 
Klinička ispitivanja kod Alzheimerove demencije Djelotvornost rivastigmina utvrđena je korištenjem tri neovisne, područno specifične ljestvice za procjenu, koje su upotrebljavane u periodičkim intervalima tijekom razdoblja liječenja od 6
The prescribed amount of solution should be withdrawn from the container using the oral dosing syringe supplied. 
Propisanu količinu otopine treba izvući iz spremnika pomoću priložene štrcaljke za oralno doziranje.
- if you have, or have ever had an active stomach ulcer. 
- ako imate ili ste imali aktivni čir želuca,
Patients with clinically significant renal or hepatic impairment might experience more adverse reactions (see sections 4.2 and 5.2). 
Posebne populacije U bolesnika s klinički značajnim oštećenjem bubrega ili jetre može se razviti više nuspojava (vidjeti dijelove 4.2 i 5.2).
- if you have, or have ever had, irregular or slow heartbeat. 
- ako imate ili ste imali nepravilne ili spore otkucaje srca,
One of the excipients in Rivastigmine Sandoz oral solution is sodium benzoate. 
Jedna od pomoćnih tvari oralne otopine Rivastigmin Sandoz je natrijev benzoat.
If you are pregnant, the benefits of using Rivastigmine Sandoz must be assessed against the possible effects on your unborn child. Rivastigmine Sandoz should not be used during pregnancy unless clearly necessary. 
Ako ste trudni, koristi primjene Rivastigmina Sandoz moraju se procijeniti u odnosu na moguće djelovanje na nerođeno dijete.
Benzoic acid is a mild irritant to the skin, eyes and mucous membranes. 
Benzojeva kiselina blago nadražuje kožu, oči i sluznice.
(n=165) n/a 
(n=165) n/p
Patients with severe hepatic impairment have not been studied, however, rivastigmine oral solution may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 
Nisu proučavani bolesnici s teškim oštećenjem jetre, no oralna otopina rivastigmina može se koristiti u ovoj populaciji bolesnika uz pažljivo praćenje (vidjeti dijelove 4.4 i 5.2).
The results for clinically relevant responders pooled from two flexible dose studies out of the three pivotal 26-week multicentre studies in patients with mild-to-moderately severe Alzheimer's Dementia, are provided in Table 4 below. 
U Tablici 4 ispod su prikazani rezultati bolesnika s klinički relevantnim odgovorom, iz udruženih rezultata dva ispitivanja s fleksibilnom dozom, od tri osnovna multicentrična ispitivanja u trajanju od 26 tjedana u bolesnika s blagom do umjereno teškom Alzheimerovom demencijom.
• Push down and turn the child resistant cap to open bottle. 
• Pritisnite i okrenite sigurnosni zatvarač te otvorite bočicu.
Hallucinations Aggression, restlessness 
Depresija Halucinacije Agresivnost, nemir
- if you have gastrointestinal reactions such as feeling sick (nausea), being sick (vomiting) and diarrhoea. 
- ako imate probavne reakcije poput osjećaja mučnine, povraćanja i proljeva.
Business Park Sofia, buil. 
Representative office Sandoz d.d. Business Park Sofia, buil. 7B, fl.
- Printing ink: - Shellac - Titanium dioxide (E171) 
Tinta za ispis: - šelak - titanijev dioksid (E171)
• Tell your caregiver that you are taking Rivastigmine Sandoz. 
• Recite osobi koja Vas njeguje da uzimate Rivastigmin Sandoz.
(n=289) n/a 
(n=289) n/p
Quinoline yellow WS dye (E104) Purified water 
(E104) i pročišćena voda.
(n=158) n/a 
(n=158) n/p
Rivastigmine Sandoz 3 mg and 6 mg hard capsules: 
Rivastigmin Sandoz 3 mg i 6 mg tvrde kapsule:
• The highest dose that should be taken is 6.0 mg twice a day. 
• Najviša doza koju smijete uzimati je 6 mg dva puta na dan.
The active substance of Rivastigmine Sandoz is rivastigmine. 
Djelatna tvar Rivastigmina Sandoz je rivastigmin.
Rare (may affect up to 1 in 1,000 people) 
Rijetko (pojavljuje se u 1 na 1000 osoba)
E-mail: uk.drugsafety@sandoz.com 
E-pošta: uk.drugsafety@sandoz.com
IE-Bantry Co. Cork Tel: +353 27 50077 
Cork Tel: +353 27 50076
Rivastigmine 
Rivastigmin
Benzoic acid is a mild irritant to the skin, eyes and mucous membrane. 
Benzojeva kiselina blago nadražuje kožu, oči i sluznicu.
According to its metabolism, metabolic interactions with other medicinal products appear unlikely, although rivastigmine may inhibit the butyrylcholinesterase mediated metabolism of other substances. 
Prema njegovom metabolizmu, metaboličke interakcije s drugim lijekovima ne čine se vjerojatne,
Sandoz GmbH Biochemiestrasse 10 A-6250 Kundl Austria 
Sandoz GmbH Biochemiestrasse 10 A-6250 Kundl
- if you have, or have ever had, asthma or severe respiratory disease. 
- ako imate ili ste imali otežano mokrenje, - ako imate ili ste imali napadaje, - ako imate ili ste imali astmu ili tešku bolest dišnih putova,
The patients studied had an MMSE (Mini-Mental State Examination) score of 10-24. 
Mini-Mental State Examination) vrijednost od 10-24.
Movement disorder Bradykinesia 
Bradikinezija Distonija
Therefore, the ability of patients with dementia on rivastigmine to continue driving or operating complex machines should be routinely evaluated by the treating physician. 
Zbog toga nadležan liječnik treba rutinski procijeniti sposobnost bolesnika s demencijom koji primaju rivastigmin mogu li nastaviti upravljati vozilima ili raditi na složenim strojevima.
- Capsule fill: - Microcrystalline cellulose 
- celuloza, mikrokristalična
Package leaflet: Information for the patient Rivastigmine Sandoz 2 mg/ml oral solution rivastigmine 
Uputa o lijeku: Informacija za bolesnika Rivastigmin Sandoz 2 mg/ml oralna otopina
Rivastigmine oral solution should be administered twice a day, with morning and evening meals. 
Oralnu otopinu rivastigmina treba primjenjivati dva puta dnevno, uz jutarnji i večernji obrok.
(n=329) n/a 
(n=329) n/p
How to take Rivastigmine Sandoz 
Kako uzimati Rivastigmin Sandoz
K.Valdemāra Str. 33 - 30 
Sandoz d.d. Representative Office in Latvia K.Valdemāra Str. 33 - 30
Teл. 
Λ.
Other side effects seen with transdermal patches and which may occur with the hard capsules: 
• Nepravilni otkucaji srca i slaba kontrola pokreta Ostale nuspojave primijećene s flasterima za kožu i koje se mogu javiti kod primjene tvrdih kapsula:
If adverse reactions (e.g. nausea, vomiting, abdominal pain or loss of appetite), weight decrease or worsening of extrapyramidal symptoms (e.g. tremor) in patients with dementia associated with Parkinson's disease are observed during treatment, these may respond to omitting one or more doses. 
Ako se u bolesnika s demencijom koja je povezana s Parkinsonovom bolešću tijekom liječenja uoče nuspojave (npr. mučnina, povraćanje, abdominalna bol ili gubitak teka), smanjenje tjelesne težine ili pogoršanje ekstrapiramidnih simptoma (npr. tremor), oni se mogu izbjeći izostavljanjem jedne ili više doza.
CONDITIONS OR RESTRICTIONS WITH REGARDS TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT 
UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU
• Wipe the outside of the syringe with a clean tissue. 
• Čistom maramicom obrišite vanjsku stranu štrcaljke.
- Capsule shell: - Gelatin - Titanium dioxide (E171) - Yellow iron oxide (E172) - Red iron oxide (E172) 
Ovojnica kapsule: - želatina - titanijev dioksid (E171) - željezov oksid, žuti (E172) - željezov oksid, crveni (E172)
Rivastigmine Sandoz 6 mg 
Rivastigmin Sandoz 6 mg
Π.T.Χατζηγeωργίου εταιρεία Ltd Γιλντίζ31-3042 Λεμεσός Τηλέφωνο: 00357 25372425 
Π.T.Χατζηγeωργίου εταιρεία Ltd Γιλντίζ31-3042 Λεμεσός
Very common (may affect more than 1 in 10 people) 
Vrlo često (pojavljuje se u više od 1 na 10 osoba)
Rivastigmine Sandoz 2 mg/ml oral solution 
Rivastigmin Sandoz 2 mg/ml oralna otopina
Rivastigmine Sandoz 3 mg 
Rivastigmin Sandoz 3 mg
E-mail: office.cz@sandoz.com 
E-pošta: office.cz@sandoz.com
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE 
PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE
Rivastigmine Sandoz 4.5 mg 
Rivastigmin Sandoz 4,5 mg
Each Rivastigmine Sandoz 1.5 mg capsule contains 1.5 mg of rivastigmine. 
Svaka kapsula Rivastigmina Sandoz od 1,5 mg sadrži 1,5 mg rivastigmina.
Each Rivastigmine Sandoz 3 mg capsule contains 3 mg of rivastigmine. 
Svaka kapsula Rivastigmina Sandoz od 3 mg sadrži 3 mg rivastigmina.
Each Rivastigmine Sandoz 6 mg capsule contains 6 mg of rivastigmine. 
Svaka kapsula Rivastigmina Sandoz od 6 mg sadrži 6 mg rivastigmina.
- Capsule shell: - Gelatin - Titanium dioxide (E171) - Yellow iron oxide (E172) 
Ovojnica kapsule: - želatina - titanijev dioksid (E171) - željezov oksid, žuti (E172)
Rivastigmine Sandoz 1.5 mg 
Rivastigmin Sandoz 1,5 mg
Each Rivastigmine Sandoz 4.5 mg capsule contains 4.5 mg of rivastigmine. 
Svaka kapsula Rivastigmina Sandoz od 4,5 mg sadrži 4,5 mg rivastigmina.
Rivastigmine Sandoz 1.5 mg hard capsules: 
Rivastigmin Sandoz 1,5 mg tvrde kapsule:
Dementia associated with Parkinson's Disease 
Alzheimerove bolesti i demencije povezane s Parkinsovom bolešću.
LV-1010 Riga Tel: + 371 67892006 
Tel: + 371 67892006
Type III amber glass bottle with a child-resistant cap, dip tube and self aligning plug. 
Bočica od smeđeg stakla tipa III sa sigurnosnim zatvaračem za djecu, uronjenom cjevčicom i čepom utisnutim u grlo bočice.
- Printing ink: - Shellac - Red iron oxide (E172) 
Tinta za ispis: - šelak - željezov oksid, crveni (E172)
Cherubino LTD DELF Building 
Cherubino LTD
• Depression 
• Drhtanje
Each ml contains 2.0 mg of rivastigmine (as hydrogen tartrate). 
Svaki ml sadrži 2 mg rivastigmina (u obliku rivastigmin hidrogentartarata).
E-mail: info.hungary@sandoz.com 
E-pošta: info.hungary@sandoz.com
Only for carton box: Rivastigmine Sandoz 2 mg/ml 
Samo za kartonsku kutiju: Rivastigmin Sandoz 2 mg/ml
Rivastigmine Sandoz 4.5 mg hard capsules: 
Rivastigmin Sandoz 4,5 mg tvrde kapsule:
- if you have, or have ever had, impaired liver function. 
- ako imate ili ste imali poremećaj funkcije bubrega, - ako imate ili ste imali poremećaj funkcije jetre,
How to store Rivastigmine Sandoz 
Kako čuvati Rivastigmin Sandoz
E-mail: info.lek@sandoz.com 
E-pošta: info.lek@sandoz.com
Each ml contains rivastigmine hydrogen tartrate corresponding to 2 mg rivastigmine. 
Svaki ml sadrži rivastigmin hidrogentartarat koji odgovara 2 mg rivastigmina.
Only for carton box: Rivastigmine Sandoz 1.5 mg 
Samo za kartonsku kutiju: Rivastigmin Sandoz 1,5 mg
ITT: Intent-To-Treat; RDO: Retrieved Drop Outs; LOCF: Last Observation Carried Forward 
Retrieved Drop Outs - slučajevi koji su ispali, a uzeti su u obzir); LOCF: (engl.
Psychiatric disorders 
Psihijatrijski poremećaji Često
Very common Common Not known 
Vrlo rijetko Nije poznato
Each capsule contains 4.5 mg of rivastigmine (as hydrogen tartrate). 
Jedna kapsula sadrži 4,5 mg rivastigmina (u obliku rivastigmin hidrogentartarata).
H-1114 Budapest Tel.: + 36 1 430 2890 
Tel.: + 36 1 430 2890
Nightmares 
• Noćne more
Musculoskeletal stiffness Rigors 
Poremećaj hoda Mišićna rigidnost Poremećaj ravnoteže Muskuloskeletna ukočenost
Off-white to slightly yellow powder in a capsule with yellow cap and yellow body, with red imprint “RIV 1.5 mg” on the body. 
Bjelkasti do žućkasti prašak u kapsuli sa žutom kapicom i žutim tijelom s crvenom oznakom „RIV 1,5 mg“ na tijelu.
- Rivastigmine Sandoz 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with a red imprint “RIV 1.5 mg” on the body. 
- Rivastigmin Sandoz 1,5 mg tvrde kapsule, koje sadrže bjelkasti do žućkasti prašak, imaju žutu kapicu i žuto tijelo s crvenom oznakom „RIV 1,5 mg“.
DK-2300 Kööpenhamina S/Köpenhamn S E-mail: info.sandoz-dk@sandoz.com 
DK-2300 Kööpenhamina S/Köpenhamn S E-pošta: info.sandoz-dk@sandoz.com
Off-white to slightly yellow powder in a capsule with red cap and red body, with white imprint “RIV 4.5 mg” on the body. 
Bjelkasti do žućkasti prašak u kapsuli s crvenom kapicom i crvenim tijelom s bijelom oznakom „RIV 4,5 mg“ na tijelu.
Each capsule contains rivastigmine hydrogen tartrate corresponding to 6mg rivastigmine. 
Svaka kapsula sadrži rivastigmin hidrogentartarat koji odgovara 6 mg rivastigmina.
E-mail: info.sandoz-nl@sandoz.com 
E-pošta: info.sandoz-nl@sandoz.com
PSURs 
Proljev
Only for carton box: Rivastigmine Sandoz 6 mg 
Samo za kartonsku kutiju: Rivastigmin Sandoz 6 mg
Only for carton box: Rivastigmine Sandoz 4.5 mg 
Samo za kartonsku kutiju: Rivastigmin Sandoz 4,5 mg
Rivastigmine Sandoz 4.5 mg hard capsules rivastigmine (as hydrogen tartrate) 
Rivastigmin Sandoz 4,5 mg tvrde kapsule rivastigmin (u obliku rivastigmin hidrogentartarata)
Each capsule contains rivastigmine hydrogen tartrate corresponding to 1,5mg rivastigmine. 
Svaka kapsula sadrži rivastigmin hidrogentartarat koji odgovara 1,5 mg rivastigmina.
Each capsule contains 6 mg of rivastigmine (as hydrogen tartrate). 
Jedna kapsula sadrži 6 mg rivastigmina (u obliku rivastigmin hidrogentartarata).
Each capsule contains rivastigmine hydrogen tartrate corresponding to 4,5mg rivastigmine. 
Svaka kapsula sadrži rivastigmin hidrogentartarat koji odgovara 4,5 mg rivastigmina.
Oral solution Novartis Pharma GmbH Roonstrasse 25 
Oralna otopina Novartis Pharma GmbH Roonstrasse 25 D-90429 Nürnberg
- Rivastigmine Sandoz 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “RIV 4.5 mg” on the body. 
- Rivastigmin Sandoz 4,5 mg tvrde kapsule, koje sadrže bjelkasti do žućkasti prašak, imaju crvenu kapicu i crveno tijelo s bijelom oznakom „RIV 4,5 mg“.
Each capsule contains 1.5 mg of rivastigmine (as hydrogen tartrate). 
Jedna kapsula sadrži 1,5 mg rivastigmina (u obliku rivastigmin hidrogentartarata).
Only for carton box: Rivastigmine Sandoz 3 mg 
Samo za kartonsku kutiju: Rivastigmin Sandoz 3 mg
DK-2300 København S E-mail: info.sandoz-dk@sandoz.com 
DK-2300 København S E-pošta: info.sandoz-dk@sandoz.com
Abdominal pain and dyspepsia Salivary hypersecretion 
Proljev Bol u abdomenu i dispepsija
Agitation Confusion Anxiety Nightmares Insomnia Depression Hallucinations 
Omaglica Glavobolja Somnolencija Tremor Sinkopa Napadaji
Balance disorder 
Poremećaj kretanja
• Fainting or accidentally falling 
• Teškoće sa spavanjem • Nesvjestica ili nehotično padanje
Rivastigmine Sandoz 6 mg hard capsules rivastigmine (as hydrogen tartrate) 
Rivastigmin Sandoz 6 mg tvrde kapsule rivastigmin (u obliku rivastigmin hidrogentartarata)
Rivastigmine Sandoz 1.5 mg hard capsules rivastigmine (as hydrogen tartrate) 
Rivastigmin Sandoz 1,5 mg tvrde kapsule rivastigmin (u obliku rivastigmin hidrogentartarata)
Each capsule contains 3 mg of rivastigmine (as hydrogen tartrate). 
Jedna kapsula sadrži 3 mg rivastigmina (u obliku rivastigmin hidrogentartarata).
Rivastigmine Sandoz 2 mg/ml oral solution rivastigmine (as hydrogen tartrate) 
Rivastigmin Sandoz 2 mg/ml oralna otopina rivastigmin (u obliku rivastigmin hidrogentartarata)
- Rivastigmine Sandoz 6 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “RIV 6 mg” on the body. 
- Rivastigmin Sandoz 6 mg tvrde kapsule, koje sadrže bjelkasti do žućkasti prašak, imaju crvenu kapicu i narančasto tijelo s crvenom oznakom „RIV 6 mg“.
DK-2300 Köpenhamn S E-mail: info.sandoz-dk@sandoz.com 
DK-2300 Köpenhamn S E-pošta: info.sandoz-dk@sandoz.com
Off-white to slightly yellow powder in a capsule with red cap and orange body, with red imprint “RIV 6 mg” on the body. 
Bjelkasti do žućkasti prašak u kapsuli s crvenom kapicom i narančastim tijelom s crvenom oznakom „RIV 6 mg“ na tijelu.
Rivastigmine Sandoz 3 mg hard capsules rivastigmine (as hydrogen tartrate) 
Rivastigmin Sandoz 3 mg tvrde kapsule rivastigmin (u obliku rivastigmin hidrogentartarata)
Abdominal pain and dyspepsia Gastric and duodenal ulcers Gastrointestinal haemorrhage Pancreatitis 
Bol u abdomenu i dispepsija Ulkusi želuca i dvanaesnika Gastrointestinalno krvarenje
Each capsule contains rivastigmine hydrogen tartrate corresponding to 3mg rivastigmine. 
Svaka kapsula sadrži rivastigmin hidrogentartarat koji odgovara 3 mg rivastigmina.
- Rivastigmine Sandoz 3 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “RIV 3 mg” on the body. 
- Rivastigmin Sandoz 3 mg tvrde kapsule , koje sadrže bjelkasti do žućkasti prašak, imaju narančastu kapicu i narančasto tijelo s crvenom oznakom „RIV 3 mg“.
Common (may affect up to 1 in 10 people) 
Često (pojavljuje se u 1 na 10 osoba)
Off-white to slightly yellow powder in a capsule with orange cap and orange body, with red imprint “RIV 3 mg” on the body. 
Bjelkasti do žućkasti prašak u kapsuli s narančastom kapicom i narančastim tijelom s crvenom oznakom „RIV 3 mg“ na tijelu.
Hepatic impairment 
Poremećaj hoda
Uncommon (may affect up to 1 in 100 people) 
Manje često (pojavljuje se u 1 na 100 osoba)
These include the ADAS-Cog (Alzheimer's Disease Assessment Scale - Cognitive subscale, a performance based measure of cognition), the CIBIC-Plus (Clinician's Interview Based Impression of Change-Plus, a comprehensive global assessment of the patient by the physician incorporating caregiver input), and the PDS (Progressive Deterioration Scale, a caregiver-rated assessment of the activities of daily living including personal hygiene, feeding, dressing, household chores such as shopping, retention of ability to orient oneself to surroundings as well as involvement in activities relating to finances, etc.). 
uključujući osobnu higijenu, hranjenje, oblačenje, poslove vezane za domaćinstvo kao što su odlazak u kupovinu, očuvanje sposobnosti orijentiranja u okolini, kao i uključivanje u aktivnosti koje se odnose na financije itd.).
Other side effects seen with transdermal patches and which may occur with the oral solution: 
Ostale nuspojave primijećene s flasterima za kožu i koje se mogu javiti kod primjene oralne otopine: Često (pojavljuju se u 1 na 10 osoba)
Patients involved in this study had an MMSE (Mini-Mental State Examination) score of 10-24. 
Ispitivani bolesnici imali su broj bodova od 10 - 24 na MMSE ljestvici (engl.
NAME OF THE MARKETING AUTHORISATION HOLDER 
ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET
Parkinsonism 
Parkinsonizam Hipokinezija
The following additional adverse reaction has been observed in a study of patients with dementia associated with Parkinson's disease treated with rivastigmine transdermal patches: agitation (common). 
Parkinsonovom bolešću liječenih rivastigminskim transdermalnim flasterima: agitacija (često).
Taking this medicine 
PRIMJENU LIJEKA
Each ml contains rivastigmine hydrogen tartrate corresponding to rivastigmine base 2.0 mg. - The other ingredients are: sodium benzoate, citric acid, sodium citrate, quinoline yellow WS dye (E104) and purified water. 
- natrijev benzoat - citratna kiselina - natrijev citrat - kinolin žuta boja WS (E104)
Absorption 
Agresivnost
Anxiety 
Tjeskoba
Common Not known 
Rijetko Nije poznato
Renal impairment 
Tremor Omaglica
D. CONDITIONS OR RESTRICTIONS WITH REGARDS TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT 
UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I
Clinical studies in Alzheimer's dementia 
Alzheimerove bolesti.
Hepatobiliary disorders 
Diskinezija Parkinsonizam Hipokinezija
It is available as tablets (1, 3, 5 and 7 mg). 
Dostupan je u obliku tableta (1, 3, 5 i 7 mg).
Inlyta axitinib 
Inlyta aksitinib
‘Advanced' means that the cancer has started to spread. 
„Uznapredovano“ znači da se rak počeo širiti.
The European Commission granted a marketing authorisation valid throughout the European Union for Inlyta on 3 September 2012. 
Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Inlyta na snazi u Europskoj uniji od 3. rujna 2012.
The dose can be adjusted according to the patient's response. 
Doza se može prilagoditi u skladu s odgovorom bolesnika.
The main measure of effectiveness was how long the patients lived without their tumour getting worse. 
Glavna mjera djelotvornosti bilo je koliko su dugo bolesnici živjeli bez pogoršanja tumora.
Regarding its safety, the side effects of the medicine are similar to other medicines in the same class and are considered to be acceptable and manageable. 
Vezano uz sigurnost lijeka, nuspojave lijeka slične su kao i u drugih lijekova iste klase i smatraju se prihvatljivima i upravljivima.
The recommended starting dose is 5 mg twice a day, taken approximately 12 hours apart. 
Preporučena početna doza iznosi 5 mg dva puta na dan, koja se uzima otprilike u razmaku od 12 sati.